{"filing":{"accession_number":"0001553350-26-000093","cik":"0001799191","ticker":"TOIIW","company_name":"Oncology Institute, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"toi_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/toi_8k.htm"},"events":[{"id":11893,"run_id":10467,"accession_number":"0001553350-26-000093","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 17, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of BDO USA as independent auditor, Say-on-Pay advisory vote approval, and Say-on-Frequency advisory vote (annual frequency approved). The detailed vote tallies for each proposal and nominee are provided, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance.","company_name":"Oncology Institute, Inc.","ticker":"TOIIW","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8603,"accession_number":"0001553350-26-000093","item_number":"5.07","item_title":"Submission of Matters to a Vote of","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 17, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of BDO USA as independent auditor, Say-on-Pay advisory vote approval, and Say-on-Frequency advisory vote (annual frequency approved). The detailed vote tallies for each proposal and nominee are provided, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:26.586997+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8603,"accession_number":"0001553350-26-000093","item_number":"5.07","item_title":"Submission of Matters to a Vote of","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 17, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of BDO USA as independent auditor, Say-on-Pay advisory vote approval, and Say-on-Frequency advisory vote (annual frequency approved). The detailed vote tallies for each proposal and nominee are provided, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:26.586997+00:00","company_name":"Oncology Institute, Inc.","ticker":"TOIIW","filing_date":"2026-06-18"}]}
